title: Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine.
abstract: BACKGROUND
  gamma-Vinyl GABA (GVG) irreversibly inhibits GABA-transaminase. This non-receptor mediated inhibition requires de novo synthesis for restoration of functional GABA catabolism.
  
  
  OBJECTIVE
  Given its preclinical success for treating substance abuse and the increased risk of visual field defects (VFD) associated with cumulative lifetime exposure, we explored the effects of sub-chronic low dose GVG on cocaine-induced increases in nucleus accumbens (NAcc) dopamine (DA).
  
  
  METHODS
  Using in vivo microdialysis, we compared acute exposure (450 mg/kg) to an identical sub-chronic exposure (150 mg/kg per day for 3 days), followed by 1- or 3-day washout. Finally, we examined the low dose of 150 mg/kg (50 mg/kg per day) using a similar washout period.
  
  
  RESULTS
  Sub-chronic GVG exposure inhibited the effect of cocaine for 3 days, which exceeded in magnitude and duration the identical acute dose.
  
  
  CONCLUSIONS
  Sub-chronic low dose GVG potentiates and extends the inhibition of cocaine-induced increases in dopamine, effectively reducing cumulative exposures and the risk for VFDS.
authors.affiliation: Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794, USA. wynne@bnl.gov
authors.forename: Wynne K
authors.initials: WK
authors.lastname: Schiffer
authors.forename: Douglas
authors.initials: D
authors.lastname: Marsteller
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Dewey
mesh_terms: D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D019970:Cocaine-Related Disorders / Q000188:drug therapy*; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D008297:Male; D017551:Microdialysis; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D020888:Vigabatrin / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin; D003042:Cocaine; D004298:Dopamine